Archive: 14/06/2016

Targeting pancreatic cancer through signalling

Researchers have identified a new way to tailor treatments for patients with pancreatic cancer, one of the most deadly forms of cancer. Currently only five per cent of people with pancreatic cancer survive longer than five ...

page 8 from 10